Issued 2026-09-16 at $2.68 · now $2.68 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, PLX has typically landed between $2.12 and $3.63 — a range of −21.0% to +35.6% from the issuance price $2.68.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
4,999 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($2.68) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where PLX has typically landed a month from the 2026-09-16 close of $2.68 — the range is history, not a prediction.
- now $2.68 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $2.69 (+0.4%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $2.4–$2.98
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $2.12–$3.63
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2007-10-24 | −88.9% | −88.9% | +0.0% |
| 2007-10-22 | −88.2% | −88.2% | +0.0% |
| 2007-10-23 | −88.0% | −88.0% | +0.8% |
| 3 best | |||
| 2017-01-12 | +223.5% | +0.0% | +223.5% |
| 2017-01-13 | +190.7% | +0.0% | +204.7% |
| 2017-01-17 | +171.7% | +0.0% | +184.8% |
4,999 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-19 | Bashan Dror | director | Purchase | 56,000 @ $1.81 | $101K | +42.3% of holding | +19.6% | +21.2% | 188,516 | Form 4 · filed 4 days after the trade |
| 2025-11-18 | Bar-Shalev Amos | director | Sale | 168 @ $1.87 | $314 | −100.0% of holding | −6.7% | −5.2% | 0 | Form 4 · filed 1 day after the trade |
| 2025-06-10 | Schwartz Aharon | director | Purchase | 129,000 @ $1.60 | $206K | +74.1% of holding | −14.5% | −3.1% | 303,000 | Form 4 · filed 63 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
45 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-03 | Bashan Dror | director | Award / grant | 160,000 | 160,000 | Form 4 |
| 2026-09-03 | Bar-Shalev Amos | director | Award / grant | 17,000 | 17,000 | Form 4 |
| 2026-09-03 | Schwartz Aharon | director | Award / grant | 8,500 | 8,500 | Form 4 |
| 2026-09-03 | Schwartz Aharon | director | Award / grant | 17,000 | 17,000 | Form 4 |
| 2026-09-03 | Bar-Shalev Amos | director | Award / grant | 8,500 | 8,500 | Form 4 |
| 2026-09-03 | Bashan Dror | director | Award / grant | 320,000 | 320,000 | Form 4 |
| 2026-09-03 | Ben Zvi Shmuel | director | Award / grant | 8,500 | 8,500 | Form 4 |
| 2026-09-03 | Ben Zvi Shmuel | director | Award / grant | 17,000 | 17,000 | Form 4 |
| 2026-09-03 | Boudes Pol F | director | Award / grant | 17,000 | 17,000 | Form 4 |
| 2026-09-03 | Boudes Pol F | director | Award / grant | 8,500 | 8,500 | Form 4 |
| 2026-09-03 | Elze Christian | director | Award / grant | 17,000 | 17,000 | Form 4 |
| 2026-09-03 | Elze Christian | director | Award / grant | 8,500 | 8,500 | Form 4 |
| 2026-09-03 | Forster Eliot | director | Award / grant | 17,000 | 17,000 | Form 4 |
| 2026-09-03 | Forster Eliot | director | Award / grant | 8,500 | 8,500 | Form 4 |
| 2026-09-03 | Melincoff Gwen A | director | Award / grant | 17,000 | 17,000 | Form 4 |
| 2026-09-03 | Melincoff Gwen A | director | Award / grant | 8,500 | 8,500 | Form 4 |
| 2026-09-03 | Naos Yaron | officer | Award / grant | 112,000 | 112,000 | Form 4 |
| 2026-09-03 | Naos Yaron | officer | Award / grant | 56,000 | 56,000 | Form 4 |
| 2025-09-03 | Bar-Shalev Amos | director | Award / grant | 15,000 | 15,000 | Form 4 |
| 2025-09-03 | Naos Yaron | officer | Award / grant | 50,000 | 50,000 | Form 4 |
| 2025-09-03 | Schwartz Aharon | director | Award / grant | 15,000 | 15,000 | Form 4 |
| 2025-09-03 | Melincoff Gwen A | director | Award / grant | 15,000 | 15,000 | Form 4 |
| 2025-09-03 | Bashan Dror | director | Award / grant | 340,000 | 340,000 | Form 4 |
| 2025-09-03 | Ben Zvi Shmuel | director | Award / grant | 15,000 | 15,000 | Form 4 |
| 2025-09-03 | Boudes Pol F | director | Award / grant | 15,000 | 15,000 | Form 4 |
| 2025-09-03 | Elze Christian | director | Award / grant | 15,000 | 15,000 | Form 4 |
| 2025-09-03 | Forster Eliot | director | Award / grant | 15,000 | 15,000 | Form 4 |
| 2025-09-03 | Elze Christian | director | Award / grant | 7,500 | 7,500 | Form 4 |
| 2025-09-03 | Schwartz Aharon | director | Award / grant | 7,500 | 7,500 | Form 4 |
| 2025-09-03 | Boudes Pol F | director | Award / grant | 7,500 | 7,500 | Form 4 |
| 2025-09-03 | Forster Eliot | director | Award / grant | 7,500 | 7,500 | Form 4 |
| 2025-09-03 | Elze Christian | director | Award / grant | 7,500 | 7,500 | Form 4 |
| 2025-09-03 | Naos Yaron | officer | Award / grant | 25,000 | 225,817 | Form 4 |
| 2025-09-03 | Forster Eliot | director | Award / grant | 7,500 | 7,500 | Form 4 |
| 2025-09-03 | Bar-Shalev Amos | director | Award / grant | 7,500 | 7,500 | Form 4 |
| 2025-09-03 | Bar-Shalev Amos | director | Award / grant | 7,500 | 7,500 | Form 4 |
| 2025-09-03 | Ben Zvi Shmuel | director | Award / grant | 7,500 | 7,500 | Form 4 |
| 2025-09-03 | Melincoff Gwen A | director | Award / grant | 7,500 | 7,500 | Form 4 |
| 2025-09-03 | Bashan Dror | director | Award / grant | 195,000 | 2,344,418 | Form 4 |
| 2025-09-03 | Naos Yaron | officer | Award / grant | 25,000 | 225,817 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.